Healthcare has spent the past several years digitizing nearly every part of care delivery. Electronic health records, telehealth platforms, remote monitoring, AI copilots, patient portals, clinical decision support tools, and revenue cycle automation are no longer side projects; they are core infrastructure.
That shift has created a dangerous blind spot. Many healthcare organizations still treat software risk management as something that happens after the build, during testing, validation, compliance review, or release approval. That model is no longer adequate.
The next major healthcare software crisis may not come from a lack of innovation. It may come from a failure to govern innovation before it reaches patients, clinicians, data systems, and operational workflows.
Healthcare technology now changes faster than traditional oversight models were designed to handle. A single software update can affect clinical documentation, patient routing, privacy exposure, care coordination, and downstream reporting. AI raises the stakes by introducing systems that may summarize records, surface recommendations, automate administrative work, or influence how clinicians interpret information.
Risk is no longer a late-stage compliance concern. It is part of the product.
For years, regulated healthcare teams could rely on a familiar sequence: gather requirements, build the system, test the system, document the results, approve the release. This approach created structure, but it also encouraged a false sense of control. By the time risk is formally reviewed, many consequential decisions have already been made. The workflow has been designed. The data has been mapped. The integration has been built.
At that point, risk management becomes reactive. It identifies gaps after they are expensive to fix, or worse, after they have already been normalized inside the development process.
Healthcare cannot afford that pattern anymore. When digital infrastructure fails, the consequences do not stay confined to IT. They can affect patient access, provider operations, privacy obligations, revenue cycle stability, and public trust. In a software-driven healthcare economy, technology risk becomes enterprise risk.
AI adoption makes this more urgent. Some use cases are administrative and relatively low risk. Others touch clinical workflows, patient communication, triage, documentation, or decision support. The distinction matters, but many organizations do not yet have mature governance models to classify, monitor, and validate those differences.
Healthcare leaders need to stop asking only whether a tool works. They also need to ask what could happen if it works incorrectly, inconsistently, opaquely, or outside its intended use.
That requires a different operating model.
First, risk classification should begin when a requirement is created. If a feature touches protected health information, affects clinical interpretation, changes patient flow, relies on external data, automates a decision, or integrates with another system, the team should know its risk profile before development begins. That classification should shape design review, testing depth, approval paths, monitoring, and documentation.
Second, traceability should be treated as a leadership tool, not an audit artifact. Healthcare organizations need a clear line from requirement to risk, from risk to control, from control to test evidence, and from test evidence to release approval. Without that line, executives rely on scattered documentation and trust that every team interpreted the stakes correctly. That is not governance. It is hope with paperwork.
Third, validation needs to become continuous. A one-time validation mindset is not enough in an environment of frequent updates, AI model changes, evolving workflows, third-party dependencies, and shifting threat patterns. Systems should be reassessed when the software, data, workflow, vendor, or risk environment changes.
This is especially important for AI-enabled healthcare software. An AI tool may perform well in one population, setting, or workflow and behave differently in another. It may produce useful output most of the time but fail in edge cases that matter. It may automate an administrative task while quietly introducing bias, inconsistency, or documentation gaps.
Healthcare organizations do not need to reject these tools. They need to govern them with the seriousness their use cases deserve.
Risk management is too often framed as the function that slows innovation down. In healthcare technology, the opposite should be true. Mature risk management allows organizations to innovate responsibly without losing control of patient safety, data privacy, compliance, quality, or operational resilience.
Risk cannot belong to one department. Compliance teams understand regulatory obligations. Security teams understand exposure. QA teams understand failure patterns. Developers understand architecture. Clinicians understand workflow impact. Operations leaders understand what breaks when software does not match reality.
If those groups only come together at the end of the release cycle, the organization has missed its best opportunity to reduce risk.
Healthcare does not need slower technology adoption. It needs more disciplined technology adoption. The organizations that lead the next phase of digital health will build governance into the software lifecycle itself. The real question is whether healthcare leaders will treat governance as paperwork after innovation, or as the foundation that makes innovation trustworthy.
About Adam Sandman
Adam Sandman is the CEO and Founder of Inflectra, where he focuses on software quality, lifecycle management, and risk-aware delivery practices for regulated industries. He is an advocate for responsible AI adoption and the use of autonomous testing to enhance security, compliance, and resilience within complex digital ecosystems.
